NOCIL Ltd

Q2 FY25 Earnings Call Analysis

Chemicals & Petrochemicals

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention current or expected orderbook/pending orders for NOCIL Limited. However, from the discussion, some insights related to orders and demand visibility are: - Strong demand visibility for the Dahej expansion project, indicating positive order intake for expanded capacity. - Customer engagements are ongoing with traction visible across Asia, Europe, and Americas. - Several new products are in advanced stages of customer trials, expected to commercialize towards the end of the year, which should contribute to future orders. - Volume growth is expected as these new products and capacity expansions ramp up. - Long-term strategic and customer engagements suggest ongoing order pipelines in both domestic and export markets. - The company expects to start seeing volume growth in upcoming quarters from various levels of customer approvals and increased capacity utilization. No specific numbers or exact pending order value details are disclosed in the transcript.
💰

fundraise

Any current/future new fundraising through debt or equity?

- As of the information provided in the transcript, there is no specific mention of any current or future fundraising through debt or equity by NOCIL Limited. - The company is focusing on an ongoing capex of about Rs. 250 crores for capacity expansion. - About 30% of this capex had been spent by March 2025, categorized under capital work in progress (CWIP). - No details were shared about raising funds through debt or equity to finance this capex. - Management discussed operational improvements and strategic growth but did not indicate plans for new fundraising initiatives.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- NOCIL has a capex budget of Rs. 250 crores for capacity expansion. - As of March 2025, about 30% of this capex has been spent, primarily categorized as capital work in progress (CWIP). - The large part of the expenditure is expected during FY 2025-26. - Trial production for the additional facility is expected to start in H1 of FY 2026-27. - Post trials and customer approvals, revenues from the new facility are expected to begin in H2 FY 2026-27. - Current plant capacity utilization is around 65%-67%, with room to grow to 80%-90% before the new facility is commissioned. - The expected asset turnover ratio for the rubber chemicals business capex is generally between 1.8 to 2.2. - The expansion aims to support volume growth and capacity debottlenecking, particularly for key products like Dahej expansion.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- NOCIL aspires to achieve double-digit volume growth, though specific timing within the calendar year is uncertain (Page 9). - Export volumes showed moderate growth (~3-3.5%) recently, with positive momentum expected from incremental approvals and new product commercializations (Pages 4, 11). - The Dahej facility expansion targets strong demand visibility, with capacity ramp-up expected in H2 FY 26-27 after trials and approvals (Page 6, 10). - Domestic market volumes are challenged by dumping pressure; antidumping petitions are in process with outcomes expected in coming months (Pages 3, 15). - Long-term objective includes expanding global market share toward 10% in the rubber chemical space, aiming for a 10% CAGR medium to long term (Page 15). - Strategy includes a judicious mix of price and volume tactics to remain competitive and achieve growth (Pages 13, 15). - Growth is expected to come from a combination of geographical expansion, new product commercialization, and operational excellence (Page 7).
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- NOCIL aims for a medium-to-long-term volume CAGR of around 10%, targeting a 10% global market share in rubber chemicals (Page 15). - They remain confident of volume growth despite short-term challenges and see the Dahej expansion ramping up production with strong demand visibility (Pages 4, 6, 8). - EBITDA margins and operating leverage are expected to improve as volumes increase and power cost savings from stabilized turbine operations materialize (Pages 7, 13-14). - Management plans to enhance competitiveness through cost savings, optimized product mix, and volume consolidation (Page 14). - Commercialization of new niche products is underway, expected to contribute in the medium term (Page 15). - Market volatility is acknowledged; however, they emphasize operational excellence, innovation, and long-term customer engagement to sustain profitable growth (Page 15-16). - Short-term margins have contracted (from 14% in FY '24 to approx. 10% in FY '25), but are expected to stabilize with operational improvements and volume ramp-up (Pages 14-15).